Baxter International (BAX) Non-Current Deferred Tax Liability (2014 - 2018)

Baxter International's (BAX) quarterly Non-Current Deferred Tax Liability came in at $205.0 million in Q4 2018, down 26.79% year-on-year from $280.0 million in Q4 2017, and down 26.79% on a QoQ basis from $280.0 million in Q4 2017.

Baxter International (BAX) Non-Current Deferred Tax Liability (2014 - 2018) Analysis & Trends

Baxter International (BAX) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $205.0 million in Q4 2018.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 26.79% year-over-year to $205.0 million in Q4 2018; TTM through Dec 2018 was $205.0 million, a 26.79% decrease from a year earlier, with the FY2018 full-year figure at $205.0 million, down 26.79% from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2018 stood at $205.0 million, down from $280.0 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for BAX reached as high as $280.0 million in Q4 2017 and fell as low as $52.0 million in Q1 2015.
  • Historically, Non-Current Deferred Tax Liability has averaged $165.5 million across 5 years, with a median of $181.5 million in 2014.
  • Across the five-year window, Non-Current Deferred Tax Liability plunged 52.31% in 2016 and surged 201.08% in 2017, its largest moves.
  • Year by year, Non-Current Deferred Tax Liability stood at $168.0 million in 2014, then gained by 16.07% to $195.0 million in 2015, then tumbled by 52.31% to $93.0 million in 2016, then jumped by 201.08% to $280.0 million in 2017, then retreated by 26.79% to $205.0 million in 2018.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $205.0 million in Q4 2018, $280.0 million in Q4 2017, and $93.0 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2018 205.00 Mn
Dec 31, 2018 205.00 Mn
Dec 31, 2017 280.00 Mn
Dec 31, 2017 280.00 Mn
Dec 31, 2016 93.00 Mn
Dec 31, 2016 93.00 Mn
Dec 31, 2015 195.00 Mn
Dec 31, 2015 195.00 Mn
Mar 31, 2015 52.00 Mn
Mar 31, 2015 52.00 Mn
Dec 31, 2014 168.00 Mn
Dec 31, 2014 168.00 Mn